Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Hims & Hers Health Inc (HIMS)

Hims & Hers Health Inc (HIMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,757,510
  • Shares Outstanding, K 214,786
  • Annual Sales, $ 872,000 K
  • Annual Income, $ -23,550 K
  • 60-Month Beta 1.08
  • Price/Sales 5.51
  • Price/Cash Flow N/A
  • Price/Book 15.43
Trade HIMS with:

Options Overview Details

View History
  • Implied Volatility 78.71% ( -1.33%)
  • Historical Volatility 101.18%
  • IV Percentile 87%
  • IV Rank 51.01%
  • IV High 112.84% on 05/03/24
  • IV Low 43.17% on 09/14/23
  • Put/Call Vol Ratio 0.49
  • Today's Volume 53,261
  • Volume Avg (30-Day) 54,481
  • Put/Call OI Ratio 0.34
  • Today's Open Interest 322,122
  • Open Int (30-Day) 276,751

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate 0.05
  • Number of Estimates 7
  • High Estimate 0.06
  • Low Estimate 0.02
  • Prior Year -0.03
  • Growth Rate Est. (year over year) +266.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.66 +41.44%
on 05/23/24
25.74 -13.95%
on 06/18/24
+4.59 (+26.14%)
since 05/21/24
3-Month
11.20 +97.77%
on 05/03/24
25.74 -13.95%
on 06/18/24
+5.42 (+32.40%)
since 03/21/24
52-Week
5.65 +292.04%
on 10/30/23
25.74 -13.95%
on 06/18/24
+13.73 (+163.06%)
since 06/21/23

Most Recent Stories

More News
This Warren Buffett Stock is the Newest GLP-1 Weight-Loss Contender

Amid rising demand for weight management drugs, this Warren Buffett stock is the newest entry.

NVO : 141.96 (+0.69%)
LLY : 883.88 (-0.24%)
COST : 848.31 (-1.64%)
HIMS : 22.15 (-1.07%)
KR : 50.21 (-0.14%)
BRK.A : 615,001.00 (-0.36%)
BRK.B : 409.62 (+0.11%)
XRT : 75.76 (-0.03%)
WMT : 67.91 (-0.15%)
Chart of the Day: Hims & Hers Health - Good Growth in Good Sex

The Chart of the Day belongs to the sex health company Hims & Hers Health (HIMS) . I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical buy signals,...

HIMS : 22.15 (-1.07%)
Hims & Hers Health Stock Soared This Week: Here's Why

The company is still riding momentum from its recent weight loss drug announcement.

HIMS : 22.15 (-1.07%)
A New Name in Weight Loss Drugs

Novo Nordisk and Eli Lilly have soared on the popularity of GLP-1 weight loss drugs. Now Hims & Hers is trying to get in on the action with a more available and affordable option.

HIMS : 22.15 (-1.07%)
NVO : 141.96 (+0.69%)
LLY : 883.88 (-0.24%)
XPOF : 16.37 (+4.00%)
WIX : 158.32 (+0.27%)
Soaring Eli Lilly Stock Could Climb Another 24% According to a Wall Street Analyst. Is the Stock a Buy Now?

Plowing $9 billion into a manufacturing facility could help a successful tirzepatide launch reach new heights.

NVO : 141.96 (+0.69%)
BMO : 83.77 (-0.14%)
CTLT : 56.50 (+3.06%)
HIMS : 22.15 (-1.07%)
LLY : 883.88 (-0.24%)
The Ultimate Growth Stock to Buy With $20 Right Now

I challenge you to name another $20 stock with more long-term potential.

HIMS : 22.15 (-1.07%)
Is Hims & Hers Stock a Buy for GLP-1 Upside?

Hims & Hers is a digital health company that is firing on all cylinders, while improving its profit margins at a robust pace.

HIMS : 22.15 (-1.07%)
LLY : 883.88 (-0.24%)
NVO : 141.96 (+0.69%)
Hims & Hers Is Changing the Game

GLP-1s could be the product that pushes Hims & Hers over the edge to mainstream adoption.

HIMS : 22.15 (-1.07%)
Him & Hers Health Stock Soars After Cheap Weight-Loss Drug Offering

Him & Hers Health (NYSE:HIMS) is a San Francisco-based telehealth platform that connects consumers to ...

HIMS : 22.15 (-1.07%)
Stocks Settle Mixed on Hawkish Fed Comments

The S&P 500 Index ($SPX ) (SPY ) Monday closed up +0.09%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.49%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.69%. US stock indexes...

$SPX : 5,464.62 (-0.16%)
SPY : 544.51 (-0.13%)
$DOWI : 39,150.33 (+0.04%)
DIA : 391.34 (+0.04%)
$IUXX : 19,700.43 (-0.26%)
QQQ : 480.18 (-0.27%)
ZNU24 : 110-160s (-0.04%)
NCLH : 17.29 (+0.64%)
CCL : 16.07 (+0.06%)
RCL : 151.12 (+0.61%)
JBL : 113.19 (+1.25%)
TER : 148.45 (+0.34%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree...

See More

Key Turning Points

3rd Resistance Point 24.41
2nd Resistance Point 23.46
1st Resistance Point 22.81
Last Price 22.15
1st Support Level 21.21
2nd Support Level 20.26
3rd Support Level 19.61

See More

52-Week High 25.74
Last Price 22.15
Fibonacci 61.8% 18.07
Fibonacci 50% 15.69
Fibonacci 38.2% 13.32
52-Week Low 5.65

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar